Results 191 to 200 of about 1,065,720 (348)

Local Rigidity for Symplectic Billiards. [PDF]

J Geom Anal
Tsodikovich D.
europepmc   +1 more source

Integrating the Integrated Stress Response

American Journal of Respiratory Cell and Molecular Biology, 2023
Harinath Bahudhanapati, Daniel J. Kass
openaire   +2 more sources

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Stringy Corrections to Heterotic SU(3)-Geometry. [PDF]

Commun Math Phys
McOrist J, Picard S.
europepmc   +1 more source

INTEGRITY [PDF]

, 2023
openaire   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

A unified concatenation model for plasma physics: Integrability and soliton solutions. [PDF]

MethodsX
Zayed EME, El-Shater M, Arnous AH, Biswas A.   +3 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Aging Weakens Memory for Schema-Deviant Objects and Decouples Gaze Sampling from Retrieval Decisions. [PDF]

Brain Sci
Xu HZ, Huan SY.
europepmc   +1 more source

Sustainability of Artemisia umbelliformis gathering in the wild: An integration of ecological conditions and harvesting exposure

Ninon Fontaine, Perrine Gauthier, Sophie Caillon, John D. Thompson, Isabelle Boulangeat   +4 more
openalex   +1 more source